SCHEMBL3141983

SCHEMBL3141983

CN(C)Cc1cccc(N/C(=C2\C(=O)Nc3cc(C(=O)O)ccc32)c2ccccc2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 1/20 0.39
MITF O75030 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
ROCK2 O75116 3/20 0.38
NR1H4 Q96RI1 2/20 0.38
FNTA P49354 1/20 0.37
FNTB P49356 1/20 0.37
KDM1A O60341 1/20 0.37
RCOR1 Q9UKL0 1/20 0.37
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEP1B Q16820 1/20 0.36
HIF1A Q16665 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3141992 1.00 PTGES (0.40) PTGESRAB9ANPC1MITFMAPK1
SCHEMBL16685264 0.93 ROCK2 (0.46) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL29354347 0.93 ROCK2 (0.46) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL16685268 0.93 ROCK2 (0.46) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL16685266 0.93 ROCK2 (0.46) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL29351460 0.93 PTGES (0.39) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL12700719 0.93 PTGES (0.39) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL16684970 0.93 PTGES (0.39) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL16684971 0.93 PTGES (0.39) PTGESKMT2AROCK2KDM1ARCOR1
SCHEMBL3148074 0.92 PTGES (0.41) PTGESKMT2AROCK2KDM1ARCOR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2157081-A1 Indolinones substituted in six locations, their manufacture and their application as medicine Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2010-02-24 EP disclosed
US-6762180-B1 Substituted indolines which inhibit receptor tyrosine kinases BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-07-13 US disclosed
EP-1224170-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT Boehringer Ingelheim Pharma KG (DE) 2002-07-24 EP disclosed
WO-2001027081-A1 6-POSITION SUBSTITUTED INDOLINE, PRODUCTION AND USE THEREOF AS A MEDICAMENT BOEHRINGER INGELHEIM PHARMA KG (DE) 2001-04-19 WO disclosed